James J. Ferguson's most recent trade in Cadrenal Therapeutics Inc was a trade of 60,000 Stock Options done . Disclosure was reported to the exchange on Feb. 5, 2025.
Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
---|---|---|---|---|---|---|---|---|---|---|
Cadrenal Therapeutics Inc
|
James J. Ferguson | Chief Medical Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 05 Feb 2025 | 60,000 | 60,000 | - | - | Stock Options |